WASHINGTON DC - A Johnson & Johnson foot gel used by diabetics may increase the risk of cancer and death, U.S. health officials said on Thursday in announcing an investigation into the issue.
The Food and Drug Administration said a study of the gel, called Regranex, found an increase in the number of cancer deaths among patients who had been prescribed the gel three or more times. More... Discount Magazine Subscriptions - Discount Cigarettes & Tobacco - Nutty News Marketplace - Blue Dolphin Group
The Food and Drug Administration said a study of the gel, called Regranex, found an increase in the number of cancer deaths among patients who had been prescribed the gel three or more times. More... Discount Magazine Subscriptions - Discount Cigarettes & Tobacco - Nutty News Marketplace - Blue Dolphin Group
